A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c

NCT03048253 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: OrienX010

Sponsor

OrienGene Biotechnology Ltd.